(CTSH) Cognizant Technology - Overview
Sector: TechnologyIndustry: Information Technology Services | Exchange NASDAQ (USA) | Currency USD | Market Cap: 28.857m | Total Return -21.6% in 12m
Stock: Consulting, Technology, Outsourcing, Automation, Digital
Total Rating 58
Risk 89
Buy Signal -1.08
| Risk 5d forecast | |
|---|---|
| Volatility | 26.7% |
| Relative Tail Risk | -4.20% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.76 |
| Alpha | -33.24 |
| Character TTM | |
|---|---|
| Beta | 0.828 |
| Beta Downside | 1.018 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.74% |
| CAGR/Max DD | 0.03 |
EPS (Earnings per Share)
Revenue
Description: CTSH Cognizant Technology March 05, 2026
Cognizant Technology Solutions Corporation (CTSH) is a professional services company. It delivers consulting, technology, and outsourcing services across North America, Europe, and other international markets.
The company operates through four segments: Financial Services, Health Sciences, Products and Resources, and Communications, Media & Technology. This structure is common among large IT services firms, allowing specialization in diverse client industries.
CTSH offers a range of services including AI and other technology solutions, consulting, application development, systems integration, and business process automation. Its focus on AI-led automation and digital experience services reflects a broader industry trend towards leveraging advanced technologies for business transformation.
The company serves a wide array of industries, including healthcare, financial services, manufacturing, retail, and communications. Its strategic partnership with Uniphore Technologies Inc. for AI solution development highlights its commitment to innovation in this rapidly evolving sector. For more detailed financial and operational insights, consider exploring ValueRay.
Headlines to watch out for
- Financial services sector spending impacts consulting and technology demand
- Healthcare industry IT budgets drive service revenue
- AI and automation adoption fuels growth in professional services
- Global economic slowdown reduces enterprise technology spending
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 2.23b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 3.39 > 1.0 |
| NWC/Revenue: 23.18% < 20% (prev 19.86%; Δ 3.32% < -1%) |
| CFO/TA 0.14 > 3% & CFO 2.88b > Net Income 2.23b |
| Net Debt (-326.0m) to EBITDA (4.07b): -0.08 < 3 |
| Current Ratio: 2.34 > 1.5 & < 3 |
| Outstanding Shares: last quarter (482.0m) vs 12m ago -3.02% < -2% |
| Gross Margin: 33.05% > 18% (prev 0.34%; Δ 3.27k% > 0.5%) |
| Asset Turnover: 103.8% > 50% (prev 98.85%; Δ 4.98% > 0%) |
| Interest Coverage Ratio: 95.03 > 6 (EBITDA TTM 4.07b / Interest Expense TTM 37.0m) |
Altman Z'' 7.88
| A: 0.24 (Total Current Assets 8.55b - Total Current Liabilities 3.66b) / Total Assets 20.69b |
| B: 0.73 (Retained Earnings 15.16b / Total Assets 20.69b) |
| C: 0.17 (EBIT TTM 3.52b / Avg Total Assets 20.33b) |
| D: 2.64 (Book Value of Equity 15.00b / Total Liabilities 5.68b) |
| Altman-Z'' Score: 7.88 = AAA |
Beneish M -2.99
| DSRI: 1.02 (Receivables 4.44b/4.06b, Revenue 21.11b/19.74b) |
| GMI: 1.04 (GM 33.05% / 34.34%) |
| AQI: 0.94 (AQ_t 0.51 / AQ_t-1 0.55) |
| SGI: 1.07 (Revenue 21.11b / 19.74b) |
| TATA: -0.03 (NI 2.23b - CFO 2.88b) / TA 20.69b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of CTSH shares?
As of March 29, 2026, the stock is trading at USD 59.73 with a total of 3,684,834 shares traded.
Over the past week, the price has changed by -3.77%, over one month by -7.29%, over three months by -29.37% and over the past year by -21.63%.
Over the past week, the price has changed by -3.77%, over one month by -7.29%, over three months by -29.37% and over the past year by -21.63%.
Is CTSH a buy, sell or hold?
Cognizant Technology has received a consensus analysts rating of 3.33.
Therefor, it is recommend to hold CTSH.
- StrongBuy: 4
- Buy: 3
- Hold: 19
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the CTSH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 87.9 | 47.1% |
| Analysts Target Price | 87.9 | 47.1% |
CTSH Fundamental Data Overview March 26, 2026
P/E Trailing = 13.1118
P/E Forward = 10.989
P/S = 1.3671
P/B = 1.9773
P/EG = 1.0174
Revenue TTM = 21.11b USD
EBIT TTM = 3.52b USD
EBITDA TTM = 4.07b USD
Long Term Debt = 543.0m USD (from longTermDebt, last quarter)
Short Term Debt = 186.0m USD (from shortTermDebt, last quarter)
Debt = 1.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -326.0m USD (from netDebt column, last quarter)
Enterprise Value = 28.52b USD (28.86b + Debt 1.57b - CCE 1.91b)
Interest Coverage Ratio = 95.03 (Ebit TTM 3.52b / Interest Expense TTM 37.0m)
EV/FCF = 10.99x (Enterprise Value 28.52b / FCF TTM 2.60b)
FCF Yield = 9.10% (FCF TTM 2.60b / Enterprise Value 28.52b)
FCF Margin = 12.29% (FCF TTM 2.60b / Revenue TTM 21.11b)
Net Margin = 10.56% (Net Income TTM 2.23b / Revenue TTM 21.11b)
Gross Margin = 33.05% ((Revenue TTM 21.11b - Cost of Revenue TTM 14.13b) / Revenue TTM)
Gross Margin QoQ = 31.11% (prev 33.87%)
Tobins Q-Ratio = 1.38 (Enterprise Value 28.52b / Total Assets 20.69b)
Interest Expense / Debt = 0.51% (Interest Expense 8.00m / Debt 1.57b)
Taxrate = 26.61% (235.0m / 883.0m)
NOPAT = 2.58b (EBIT 3.52b * (1 - 26.61%))
Current Ratio = 2.34 (Total Current Assets 8.55b / Total Current Liabilities 3.66b)
Debt / Equity = 0.10 (Debt 1.57b / totalStockholderEquity, last quarter 15.02b)
Debt / EBITDA = -0.08 (Net Debt -326.0m / EBITDA 4.07b)
Debt / FCF = -0.13 (Net Debt -326.0m / FCF TTM 2.60b)
Total Stockholder Equity = 15.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.97% (Net Income 2.23b / Total Assets 20.69b)
RoE = 14.84% (Net Income TTM 2.23b / Total Stockholder Equity 15.02b)
RoCE = 22.59% (EBIT 3.52b / Capital Employed (Equity 15.02b + L.T.Debt 543.0m))
RoIC = 16.53% (NOPAT 2.58b / Invested Capital 15.61b)
WACC = 8.45% (E(28.86b)/V(30.43b) * Re(8.89%) + D(1.57b)/V(30.43b) * Rd(0.51%) * (1-Tc(0.27)))
Discount Rate = 8.89% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.91%
[DCF] Terminal Value 75.77% ; FCFF base≈2.29b ; Y1≈2.14b ; Y5≈1.99b
[DCF] Fair Price = 69.94 (EV 33.12b - Net Debt -326.0m = Equity 33.45b / Shares 478.2m; r=8.45% [WACC]; 5y FCF grow -8.14% → 3.0% )
EPS Correlation: 63.74 | EPS CAGR: 6.13% | SUE: 0.72 | # QB: 0
Revenue Correlation: 79.62 | Revenue CAGR: 2.70% | SUE: 0.67 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.40 | Chg7d=+0.000 | Chg30d=-0.000 | Revisions Net=+5 | Analysts=21
EPS current Year (2026-12-31): EPS=5.66 | Chg7d=+0.001 | Chg30d=+0.005 | Revisions Net=+2 | Growth EPS=+7.2% | Growth Revenue=+6.0%
EPS next Year (2027-12-31): EPS=6.15 | Chg7d=-0.000 | Chg30d=-0.008 | Revisions Net=-2 | Growth EPS=+8.6% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: +0.33 (10 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.3% (Discount Rate 8.9% - Earnings Yield 7.6%)
[Growth] Growth Spread = +4.8% (Analyst 6.1% - Implied 1.3%)
P/E Forward = 10.989
P/S = 1.3671
P/B = 1.9773
P/EG = 1.0174
Revenue TTM = 21.11b USD
EBIT TTM = 3.52b USD
EBITDA TTM = 4.07b USD
Long Term Debt = 543.0m USD (from longTermDebt, last quarter)
Short Term Debt = 186.0m USD (from shortTermDebt, last quarter)
Debt = 1.57b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -326.0m USD (from netDebt column, last quarter)
Enterprise Value = 28.52b USD (28.86b + Debt 1.57b - CCE 1.91b)
Interest Coverage Ratio = 95.03 (Ebit TTM 3.52b / Interest Expense TTM 37.0m)
EV/FCF = 10.99x (Enterprise Value 28.52b / FCF TTM 2.60b)
FCF Yield = 9.10% (FCF TTM 2.60b / Enterprise Value 28.52b)
FCF Margin = 12.29% (FCF TTM 2.60b / Revenue TTM 21.11b)
Net Margin = 10.56% (Net Income TTM 2.23b / Revenue TTM 21.11b)
Gross Margin = 33.05% ((Revenue TTM 21.11b - Cost of Revenue TTM 14.13b) / Revenue TTM)
Gross Margin QoQ = 31.11% (prev 33.87%)
Tobins Q-Ratio = 1.38 (Enterprise Value 28.52b / Total Assets 20.69b)
Interest Expense / Debt = 0.51% (Interest Expense 8.00m / Debt 1.57b)
Taxrate = 26.61% (235.0m / 883.0m)
NOPAT = 2.58b (EBIT 3.52b * (1 - 26.61%))
Current Ratio = 2.34 (Total Current Assets 8.55b / Total Current Liabilities 3.66b)
Debt / Equity = 0.10 (Debt 1.57b / totalStockholderEquity, last quarter 15.02b)
Debt / EBITDA = -0.08 (Net Debt -326.0m / EBITDA 4.07b)
Debt / FCF = -0.13 (Net Debt -326.0m / FCF TTM 2.60b)
Total Stockholder Equity = 15.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.97% (Net Income 2.23b / Total Assets 20.69b)
RoE = 14.84% (Net Income TTM 2.23b / Total Stockholder Equity 15.02b)
RoCE = 22.59% (EBIT 3.52b / Capital Employed (Equity 15.02b + L.T.Debt 543.0m))
RoIC = 16.53% (NOPAT 2.58b / Invested Capital 15.61b)
WACC = 8.45% (E(28.86b)/V(30.43b) * Re(8.89%) + D(1.57b)/V(30.43b) * Rd(0.51%) * (1-Tc(0.27)))
Discount Rate = 8.89% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.91%
[DCF] Terminal Value 75.77% ; FCFF base≈2.29b ; Y1≈2.14b ; Y5≈1.99b
[DCF] Fair Price = 69.94 (EV 33.12b - Net Debt -326.0m = Equity 33.45b / Shares 478.2m; r=8.45% [WACC]; 5y FCF grow -8.14% → 3.0% )
EPS Correlation: 63.74 | EPS CAGR: 6.13% | SUE: 0.72 | # QB: 0
Revenue Correlation: 79.62 | Revenue CAGR: 2.70% | SUE: 0.67 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.40 | Chg7d=+0.000 | Chg30d=-0.000 | Revisions Net=+5 | Analysts=21
EPS current Year (2026-12-31): EPS=5.66 | Chg7d=+0.001 | Chg30d=+0.005 | Revisions Net=+2 | Growth EPS=+7.2% | Growth Revenue=+6.0%
EPS next Year (2027-12-31): EPS=6.15 | Chg7d=-0.000 | Chg30d=-0.008 | Revisions Net=-2 | Growth EPS=+8.6% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: +0.33 (10 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.3% (Discount Rate 8.9% - Earnings Yield 7.6%)
[Growth] Growth Spread = +4.8% (Analyst 6.1% - Implied 1.3%)